Enflicoxib for canine osteoarthritis: A randomized, blind, multicentre, non-inferiority clinical trial compared to mavacoxib

BACKGROUND: This prospective, multisite, blinded, randomized, non-inferiority clinical study aimed to confirm the efficacy and safety of enflicoxib in the treatment of pain and inflammation associated with canine osteoarthritis. A total of 180 dogs were randomized to receive enflicoxib (n = 78), mav...

Descripción completa

Detalles Bibliográficos
Autores principales: Salichs, Marta, Badiella, Llorenç, Sarasola, Patxi, Homedes, Josep
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9488826/
https://www.ncbi.nlm.nih.gov/pubmed/36126039
http://dx.doi.org/10.1371/journal.pone.0274800

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9488826/
https://www.ncbi.nlm.nih.gov/pubmed/36126039
http://dx.doi.org/10.1371/journal.pone.0274800

Ejemplares similares